Bionic ETF
VanEck Bionic Engineering UCITS ETF | CYBO
Bionic ETF
VanEck Bionic Engineering UCITS ETF | CYBO
-
NAV$19.06
as of 01 Dec 2023 -
YTD RETURNS-3.69%
as of 01 Dec 2023 -
Total Net Assets$5.1 million
as of 01 Dec 2023 -
Total Expense Ratio0.55%
-
Inception Date02 Dec 2022
-
SFDR ClassificationArticle 9
More Info
Overview
Fund Description
As the global population ages, so does the demand for biologically-inspired systems that improve the quality of later life. VanEck’s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
- Invest in companies at the forefront of improving quality of life for the world’s ageing population
- Gain diversified exposure to companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments
- Access companies earning at least half their revenues from bionic engineering-related industries
- Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco
Risk Factors: Equity market risk, industry or sector concentration risk, risk of investing in smaller companies, technological risk. Please refer to the
and the Prospectus for other important information before investing.
Underlying Index
MVIS® Global Bionic Healthcare ESG Index (MVBIONTR)